US › Healthcare

Nyxoah (NYXH)

US · Healthcare · Medical Devices

$1.49-3.87%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$7.7M

Revenue YoY

+472.8%

Net profit

$-33.0M

EPS

$-0.67

EPS estimate

$-0.47

Net margin

-429.5%

EPS came in at -0.67 against a street estimate of -0.47 — a miss of 42.6%.

Key statistics

Market cap

$152.8M

Forward P/E

0.0

P/B

1.60

Book value

$0.96

EPS (TTM)

$-2.51

52-week high

$6.87

52-week low

$1.26

50-day MA

$1.57

200-day MA

$3.15

Beta

0.96

Analyst view

Analysts rate Nyxoah a buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $4.35.

Shareholding

Insiders

33.19%

Institutions

29.90%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nyxoah — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.